NAGE insider trading
NasdaqCM HealthcareNiagen Bioscience, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Niagen Bioscience, Inc.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Company website: www.niagenbioscience.com
NAGE insider activity at a glance
FilingIQ has scored 8 insider transactions for NAGE since Apr 9, 2025. The most recent filing in our index is dated Apr 24, 2026.
Across the full history, 2 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NAGE insider trades is 63.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for NAGE?
- FilingIQ tracks 8 Form 4 insider transactions for NAGE (Niagen Bioscience, Inc.), covering filings from Apr 9, 2025 onwards. 5 of those were filed in the last 90 days.
- Are NAGE insiders net buyers or net sellers?
- Across the full Form 4 history for NAGE, 2 transactions (25%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NAGE insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is NAGE in?
- Niagen Bioscience, Inc. (NAGE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $413.40M.
Methodology & sources
Every NAGE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.